British American Tobacco p.l.c. ADR (BTI)
British American Tobacco Isn't Cheap Enough To Justify The Risk
British American Tobacco remains a 'hold' as deteriorating fundamentals and limited upside outweigh growth in modern oral products. BTI's New Categories, particularly Velo and Vuse, are delivering strong market share gains, but core combustibles face long-term decline. Despite revenue growth, net income and EBITDA declined; cost-cutting and share buybacks are central to management's strategy.
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
British American Tobacco H1 Earnings Call Highlights
British American Tobacco NYSE: BTI said its first-half 2026 results were in line with expectations on a constant-currency basis, supported by growth in U.S. nicotine products, continued momentum for its Velo modern oral brand and resilient combustibles performance in the U.S. and AME region.
British American Tobacco: Strong Buy On Valuation And Velo Growth
British American Tobacco is rapidly expanding its non-traditional products, particularly Velo nicotine pouches, driving strong adoption among younger users. BTI offers a compelling 5%+ dividend yield and is aggressively returning capital to shareholders through stock buybacks, enhancing total shareholder returns. With a forward P/E of 11.7x, BTI trades at a significant discount to industry peers, providing a high margin of safety for investors.
British American Tobacco: A Good Diversification Play Away From AI
British American Tobacco remains a compelling buy, offering resilient profitability and a business model with inelastic demand for its core products. BTI's operating margins are impressively high for manufacturing, supported by pricing power and stable consumption despite regulatory headwinds. Debt is manageable with a 5.5x interest coverage ratio and robust cash flow, underpinning dividend stability and financial safety.
3 Tobacco Stocks to Keep an Eye on Amid Market Headwinds
PM, BTI and MO are tackling volume pressures and rising costs by expanding smoke-free portfolios and adapting to changing consumer trends.
Wall Street Analysts Think British American Tobacco (BTI) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
US senators question Big Tobacco on lobbying related to FDA policy shift
Six U.S. senators including Democratic whip Dick Durbin and Elizabeth Warren wrote public letters to tobacco giants Reynolds American and Altria on Thursday to ask questions about donations and lobbying of the Trump administration, saying the companies had enjoyed a "lucrative payday" after spending millions to curry favour with the president.
British American Tobacco p.l.c. (BTI) Q2 2026 Sales/Trading Call Transcript
British American Tobacco p.l.c. (BTI) Q2 2026 Sales/Trading Call Transcript
British American Tobacco Cuts Cigarette Outlook But Expects Lift in New-Category Revenue
The company said global industry volumes in its traditional cigarette market would likely be lower than previously expected this year.
British American Tobacco: The Cigarette Bear Case Is Too Simple
British American Tobacco offers attractive risk-adjusted returns amid regulatory upheaval, with strong revenue predictability and resilient cash flow generation. BTI's reported GAAP revenue since 2018 averages £26 billion, with low volatility, underscoring the tobacco market's ongoing stability despite health awareness and new regulations. Free cash flow margins remain robust, averaging 29% (2018–2024), except for a litigation-impacted 2025, supporting solid valuation and dividend sustainability.
